Health care industry

In this Aug. 16, 2010 file photo a nurse looks on from a window of the Giulesti hospital following a fire that left 5 newborn babies dead. Romanian health authorities on Friday, Nov. 30, 2018, temporarily closed the maternity hospital in the capital after over a dozen babies born there recently were diagnosed with a drug-resistant superbug. The Health Ministry said the hospital would stop admissions after the newborns were recently diagnosed with antibiotic-resistant Staphylococcus aureus. (AP Photo/Vadim Ghirda, File)
December 10, 2018 - 6:38 am
BUCHAREST, Romania (AP) — Romanian authorities say the number of babies diagnosed with a drug-resistant superbug at a maternity hospital in the capital has risen to 39. Raluca Alexandru, spokeswoman for Giulesti Maternity hospital, closed Nov. 30 due to the outbreak, on Monday said tests have...
Read More
FILE - In this May 25, 2018 file photo members of the supervisory board sit in front of the company logo during the annual shareholders meeting of German chemical giant Bayer AG in Bonn, Germany. Bayer said Thursday, Nov 29, 2018 it will cut 12 000 jobs, most of them in Germany. (AP Photo/Martin Meissner, file)
November 29, 2018 - 8:13 am
BERLIN (AP) — German pharmaceutical giant Bayer AG says it's cutting 12,000 jobs worldwide as it seeks to reduce costs. The Leverkusen-based company said Thursday that details of the cuts to its 118,200-stong workforce would be worked out in coming months but that "a significant number" of the...
Read More
November 28, 2018 - 5:03 pm
Australian Army veteran Wolfgang Neszpor was stunned when he heard his recently repaired shoulder squeak. "You could really hear it," he said. He recalled when the surgeon examined him and lifted up his arm, "It was a stupid amount of pain." Two months earlier, Neszpor, 36, had gotten a new...
Read More
November 26, 2018 - 11:04 am
WASHINGTON (AP) — US health officials said Monday they plan to overhaul the nation's decades-old system for approving most medical devices, which has long been criticized by experts for failing to catch problems with risky implants and medical instruments. The Food and Drug Administration announced...
Read More
CORRECTS DATE TO NOV. 19, NOT NOV. 11 - In this Nov. 19, 2018, photo, Juan Lopez stands over the body of his ex-fiancee, emergency room doctor Tamara O'Neal, after gunning her down in a parking lot near Mercy Hospital in Chicago. Lopez later fatally shot two people inside the hospital. Lopez died of gunshot wounds following the shooting. (Sam Akkadian via AP)
November 21, 2018 - 7:36 am
CHICAGO (AP) — Moments before her ex-fiance fatally shot her in the parking lot of the hospital where she worked, a Chicago doctor called 911 to report that she had spotted the man and feared for her life. As investigators tried to piece together the events that ended with the deaths of the doctor...
Read More
November 12, 2018 - 8:03 am
A prominent athenahelath investor and a private equity firm will spend about $5.7 billion on the medical billing software maker and take it private. Veritas Capital and Evergreen Coast Capital said Monday they'll pair athenahealth with a company Veritas bought earlier this year, Virence Health...
Read More
This undated image provided by AcelRx Pharmaceuticals shows the dispenser and a tablet for the company's medication Dsuvia. On Friday, Nov. 2. 2018, U.S. regulators announced the approval of the fast-acting, super-potent opioid tablet as an alternative to IV painkillers used in hospitals. (Craig Sherod Photography/AcelRx Pharmaceuticals via AP)
November 02, 2018 - 2:24 pm
TRENTON, N.J. (AP) — U.S. regulators on Friday approved a fast-acting, super-potent opioid tablet as an alternative to IV painkillers used in hospitals. The decision by the Food and Drug Administration on Friday came over objections from critics who fear the pill will be abused. In a lengthy...
Read More
FILE - In this Dec. 14, 2017 file photo, an Israeli flag flies outside a Teva Pharmaceutical Industries building, in Neot Hovav, Israel. On Thursday, Nov. 1, 2018, Israeli drug maker Teva reported a third-quarter loss as it proceeds with an aggressive cost-cutting program and adjusts to declines in key product categories. But the company gave an upbeat outlook, citing stabilization in its core generics business, the launch of new products and progress with its restructuring program. Its stock price surged on the news. (AP Photo/Tsafrir Abayov, File)
November 01, 2018 - 12:12 pm
JERUSALEM (AP) — Israeli drug maker Teva Pharmaceutical Industries on Thursday reported a third-quarter loss as it proceeds with an aggressive cost-cutting program and adjusts to declines in key product categories. But the company gave an upbeat outlook, citing stabilization in its core generics...
Read More
FILE- In this July 10, 2018, file photo bottles of medicine ride on a belt at the Express Scripts mail-in pharmacy warehouse in Florence, N.J. On Monday, Oct. 15, the industry's largest trade group announced that dozens of drugmakers will start disclosing the prices for U.S. prescription drugs advertised on TV. The prices won't actually be shown in the TV commercials but the advertisement will include a website where the list price will be posted. (AP Photo/Julio Cortez, File)
October 15, 2018 - 8:41 pm
TRENTON, N.J. (AP) — The federal government said Monday that it wants to force drugmakers to disclose prices for prescription medicines in their TV commercials. The drug industry's main trade group said drug companies are only willing to disclose the prices on their websites, not in commercials,...
Read More
FILE - IN this June 1, 2017 file photo,. a sign stands on the campus of the Aetna headquarters in Hartford, Conn. The Justice Department has agreed to Aetna’s plan to sell its Medicare Part D prescription drug plan business for individuals to fellow insurer WellCare, resolving competition concerns. Aetna announced Sept. 2018 it’d sell the business for an undisclosed amount. The move was seen as a way for CVS Health to move forward with its $69 billion takeover of Aetna. (AP Photo/Bill Sikes, File)
October 10, 2018 - 10:15 am
NEW YORK (AP) — The proposed $69 billion merger between CVS Health and Aetna is getting a greenlight from the Department of Justice, with some conditions. The Justice Department on Wednesday approved the deal on the condition that Aetna moves ahead with its plan to sell its Medicare Part D...
Read More

Pages